Physitrack PLC (PTRK) Fair Value & Analysis
Healthcare · SE · Market cap 135M SEK
Fair value as of: Jun 24, 2026
Analysis
Physitrack PLC (PTRK) currently trades at kr 8.00, while our model-based Fair Value estimate is kr 2.75 — implying the stock looks roughly 65.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Physitrack PLC, together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through two segments, Lifecare and Wellness. The company offers Physitrack, a remote therapeutic monitoring platform that provides a suite of tools for exercise program prescription, patient-reported adherence and tracking, and telehealth for private practices, occupational health and case management, healthcare systems and hospitals, and sports. It also offers Physiapp, a mobile application that allows physiotherapists to deliver personalized rehabilitation programs, track patient progress, and adjust treatments in real-time; and Physiocourses, an e-learning library for healthcare professionals. Physitrack PLC was incorporated in 2012 and is based in London, the United Kingdom.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Physitrack PLC (PTRK) undervalued?
What is the fair value of PTRK?
What is the quality score of PTRK?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.